Strong FGFR3 staining is a marker for FGFR3 fusions and poor prognosis in diffuse gliomas

被引：0
|
作者：
Granberg, Kirsi J.
Annala, Matti
Lehtinen, Birgitta
Kesseli, Juha
Haapasalo, Joonas
Yli-Harja, Olli
Visakorpi, Tapio
Haapasalo, Hannu
Nykter, Matti
Zhang, Wei
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-5011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5011
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas
    Granberg, Kirsi J.
    Annala, Matti
    Lehtinen, Birgitta
    Kesseli, Juha
    Haapasalo, Joonas
    Ruusuvuori, Pekka
    Yli-Harja, Olli
    Visakorpi, Tapio
    Haapasalo, Hannu
    Nykter, Matti
    Zhang, Wei
    NEURO-ONCOLOGY, 2017, 19 (09) : 1206 - 1216
  • [2] ULTRARAPID FGFR3 IMMUNOSTAINING FOR DIAGNOSIS OF GLIOMAS HARBORING FGFR3 GENE FUSIONS
    Mantyla, S.
    Haapasalo, J.
    Ilvesaro, J.
    Nordfors, K.
    Isola, J.
    Haapasalo, H.
    Nykter, M.
    Granberg, K.
    NEURO-ONCOLOGY, 2018, 20 : 298 - 298
  • [3] Targetable FGFR3 Fusions and Novel FGFR3 Mutations in Glioma
    Schittenhelm, Jens
    Ziegler, Lukas
    Mittelbronn, Michel
    Capper, David
    Burghardt, Isabel
    Poso, Antti
    Biskup, Saskia
    Skardelly, Marko
    Tabatabal, Ghazaleh
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 33 - 33
  • [4] FGFR3 overexpression is a useful detection tool for FGFR3 fusions and sequence variations in glioma
    Schittenhelm, Jens
    Ziegler, Lukas
    Sperveslage, Jan
    Mittelbronn, Michel
    Capper, David
    Burghardt, Isabel
    Poso, Antti
    Biskup, Saskia
    Skardelly, Marco
    Tabatabai, Ghazaleh
    NEURO-ONCOLOGY PRACTICE, 2021, 8 (02) : 209 - 221
  • [5] Effect of FGFR3 Juxtamembrane Domain on FGFR3 Dimerization
    Sarabipour, Sarvenaz
    Li, Edwin
    Hristova, Kalina
    BIOPHYSICAL JOURNAL, 2011, 100 (03) : 546 - 546
  • [6] FGFR3, a marker suggestive of favorable prognosis in urothelial carcinoma
    Khalifa S.E.
    Khairy R.A.
    Ramadan R.
    Comparative Clinical Pathology, 2017, 26 (5) : 1203 - 1208
  • [7] FGFR3 is key
    Gemma K. Alderton
    Nature Reviews Cancer, 2009, 9 : 387 - 387
  • [8] Oncogenic FGFR3 gene fusions in bladder cancer
    Williams, Sarah V.
    Hurst, Carolyn D.
    Knowles, Margaret A.
    HUMAN MOLECULAR GENETICS, 2013, 22 (04) : 795 - 803
  • [9] A kinase deleated FGFR3 inhibits FGFR3 activity in-vivo
    Zebavi-Feferman, T
    Madar-Shapiro, L
    Chumakov, I
    Rom, E
    Yayon, A
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 235A - 235A
  • [10] FGFR3 mutations and FGFR3 protein overexpression in superficial bladder tumors
    Hernandez, S.
    Lopez-Knowles, E.
    Murta, C.
    Kogevinas, M.
    Lloreta, J.
    Carrato, A.
    Tradon, A.
    Serra, C.
    Malats, N.
    Real, F. X.
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (14) : 808 - 808
12345